190 related articles for article (PubMed ID: 29503858)
1. Radiosynthesis and evaluation of an
Dialer LO; Jodal A; Schibli R; Ametamey SM; Béhé M
EJNMMI Radiopharm Chem; 2018; 3(1):1. PubMed ID: 29503858
[TBL] [Abstract][Full Text] [Related]
2. Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.
Xu Y; Pan D; Xu Q; Zhu C; Wang L; Chen F; Yang R; Luo S; Yang M
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1479-88. PubMed ID: 24838847
[TBL] [Abstract][Full Text] [Related]
3. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.
Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208
[TBL] [Abstract][Full Text] [Related]
4. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.
Kiesewetter DO; Gao H; Ma Y; Niu G; Quan Q; Guo N; Chen X
Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):463-73. PubMed ID: 22170321
[TBL] [Abstract][Full Text] [Related]
5. [
Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M
Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma.
Kiesewetter DO; Guo N; Guo J; Gao H; Zhu L; Ma Y; Niu G; Chen X
Theranostics; 2012; 2(10):999-1009. PubMed ID: 23139727
[TBL] [Abstract][Full Text] [Related]
7. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.
Gao H; Niu G; Yang M; Quan Q; Ma Y; Murage EN; Ahn JM; Kiesewetter DO; Chen X
Mol Pharm; 2011 Oct; 8(5):1775-82. PubMed ID: 21800885
[TBL] [Abstract][Full Text] [Related]
8. Development of an
Iikuni S; Kamei I; Ohara T; Watanabe H; Ono M
Mol Pharm; 2022 Mar; 19(3):1019-1027. PubMed ID: 35138111
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.
Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M
J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationships and Pharmacokinetics of
Iikuni S; Ohara T; Watanabe H; Ono M
Mol Pharm; 2022 Aug; 19(8):2832-2839. PubMed ID: 35757958
[TBL] [Abstract][Full Text] [Related]
11. Development of
Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587
[TBL] [Abstract][Full Text] [Related]
12. One-pot two-step radiosynthesis of a new (18)F-labeled thiol reactive prosthetic group and its conjugate for insulinoma imaging.
Yue X; Yan X; Wu C; Niu G; Ma Y; Jacobson O; Shen B; Kiesewetter DO; Chen X
Mol Pharm; 2014 Nov; 11(11):3875-84. PubMed ID: 24798315
[TBL] [Abstract][Full Text] [Related]
13. Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer,
Mikkola K; Yim CB; Lehtiniemi P; Kauhanen S; Tarkia M; Tolvanen T; Nuutila P; Solin O
EJNMMI Res; 2016 Dec; 6(1):91. PubMed ID: 27957723
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.
Wu Z; Liu S; Hassink M; Nair I; Park R; Li L; Todorov I; Fox JM; Li Z; Shively JE; Conti PS; Kandeel F
J Nucl Med; 2013 Feb; 54(2):244-51. PubMed ID: 23297075
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
Wild D; Antwi K; Fani M; Christ ER
J Nucl Med; 2021 Jul; 62(Suppl 2):44S-50S. PubMed ID: 34230073
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
